COVID-19 vaccination in Iran

Coronavirus. SARS-CoV-2

COVID-19 vaccination in Iran

The COVID-19 vaccination in Iran is part of the global effort to combat the COVID-19 pandemic. The vaccination campaign in Iran began in early 2021, following the emergency use authorization of several vaccines.

Vaccines Used

Iran has utilized a variety of vaccines in its COVID-19 vaccination campaign, including:

• Sputnik V
• Sinopharm BIBP COVID-19 vaccine
• AstraZeneca COVID-19 vaccine
• COVIran Barekat
• PastuCovac

Vaccination Rollout

The vaccination rollout in Iran has been managed by the Ministry of Health and Medical Education. The campaign prioritized healthcare workers, the elderly, and individuals with underlying health conditions.

Phases of Vaccination

The vaccination campaign was divided into several phases:

• Phase 1: Healthcare workers and frontline workers.
• Phase 2: Elderly population and individuals with comorbidities.
• Phase 3: General adult population.
• Phase 4: Adolescents and children, as vaccines were approved for younger age groups.

Challenges

Iran faced several challenges in its vaccination campaign, including:

• International sanctions affecting vaccine procurement.
• Vaccine hesitancy among certain segments of the population.
• Logistical issues in distributing vaccines to remote areas.

Progress and Coverage

As of [date], Iran has administered [number] doses of COVID-19 vaccines. The government aims to achieve herd immunity by vaccinating a significant portion of the population.

Public Response

The public response to the vaccination campaign has been mixed, with some expressing trust in the vaccines and others showing reluctance due to misinformation and distrust in the government.

Related Pages

• COVID-19 pandemic in Iran
• COVID-19 vaccination
• Ministry of Health and Medical Education (Iran)
• COVIran Barekat
• PastuCovac

See Also

• COVID-19 pandemic
• Vaccination
• Public health

‎